1. Multi-Morbidity at Death and the Us Disadvantage in Life Expectancy • Magali Barbieri , Institut National d'Études Démographiques (INED); Aline Désesquelles, Institut National d'Études Démographiques (INED); Viviana Egidi, Sapienza Università di Roma; Luisa Frova, Istituto Nazionale di Statistica (ISTAT); Francesco Grippo, ISTAT; France Meslé, Institut National d'Études Démographiques (INED); Marilena Pappagallo, Istat (Italian National Institute of Statistics); Sergi Trias-Llimós, Centre d'Estudis Demogràfics.

2. Unravelling the Longitudinal Dynamics of Neurodegenerative Disease Mortality: Insights from 50 Years of Belgian Demographic Data • Janna Dinneweth , Vrije Universiteit Brussel; Sylvie Gadeyne, Vrije Universiteit Brussel.

3. Why Is Life Expectancy in England & Wales Falling Behind? A Decomposition Approach • Jennifer Dowd , University of Oxford; Antonino Polizzi, University of Oxford; José Manuel Aburto, London School of Hygiene and Tropical Medicine (LSHTM); Luyin Zhang, University of Oxford; Andrea M Tilstra, University of Oxford.

4. How Change in Age-Specific Mortality Has Affected Us Life Expectancy over the Past 120 Years? • Jiaxin Shi , University of Wisconsin-Madison; Jason Fletcher, University of Wisconsin-Madison.

5. Trends in Avoidable Mortality in European Cross-Border Regions between 1992-2020 • Sophie Stroisch , University of Groningen; Pavel Grigoriev, Federal Institute for Population Research (BiB), Germany; Michael Muehlichen, Federal Institute for Population Research (BiB), Germany; Rok Hrzic, Maastricht University; Vogt Tobias, University of Groningen.

6. Gains in Life Expectancy from Decreasing Cardiovascular Disease and Cancer Mortality – an Analysis of 28 European Countries 1995-2019 • András Wéber , Hungarian National Cancer Registry; Mathieu Laversanne, International Agency for Research on Cancer; Péter Nagy, National Institute of Oncology; István Kenessey, National Institute of Oncology; Isabelle Soerjomataram, International Agency for Research on Cancer; Freddie Bray, International Agency for Research on Cancer.